Wataru Munakata

18PUBLICATIONS
45CO-AUTHORS
Haematological tumoursRespiratory diseasesCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 14, 2026
Differential Expression of CD79B, CD19, and PD-L1 in de Novo and Transformed CD20-Negative Large B-Cell Lymphomas.

Yuto Kaimi, Yuka Takahashi, Mai Takeuchi

|Dec 29, 2025
Humoral and T-cell immune responses to coronavirus disease 2019 vaccines in patients with hematological malignancies.

Haruhi Makino, Suguru Fukuhara, Keiji Okinaka

|Dec 20, 2025
Impact of Achieving Progression-Free Survival 24 on Subsequent Overall Survival in Diffuse Large B-Cell Lymphoma Patients.

Ayumi Fujimoto, Wataru Munakata, Gakuto Ogawa

|Dec 16, 2025
Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER).

Yusuke Sano, Kana Miyazaki, Motoko Yamaguchi

|Sep 02, 2025
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.

Ken Ohmachi, Tomohiro Kinoshita, Dai Maruyama

|Feb 25, 2025
Obinutuzumab maintenance versus observation for patients with newly diagnosed high tumor burden follicular lymphoma who achieved complete metabolic response after obinutuzumab plus bendamustine induction therapy: a multicenter, randomized, phase III study (JCOG2008, MAIN study).

Tsutomu Kobayashi, Kenichi Ishizawa, Ryunosuke Machida

Pageof 3

Frequent Collaborators

6 joint publications

Dai Maruyama

5 joint publications

Koji Izutsu

4 joint publications

Suguru Fukuhara

3 joint publications

Ken Ohmachi